1. Home
  2. MDGL vs OSK Comparison

MDGL vs OSK Comparison

Compare MDGL & OSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • OSK
  • Stock Information
  • Founded
  • MDGL 2011
  • OSK 1917
  • Country
  • MDGL United States
  • OSK United States
  • Employees
  • MDGL N/A
  • OSK N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • OSK Auto Manufacturing
  • Sector
  • MDGL Health Care
  • OSK Consumer Discretionary
  • Exchange
  • MDGL Nasdaq
  • OSK Nasdaq
  • Market Cap
  • MDGL 6.1B
  • OSK 5.6B
  • IPO Year
  • MDGL N/A
  • OSK N/A
  • Fundamental
  • Price
  • MDGL $440.75
  • OSK $136.19
  • Analyst Decision
  • MDGL Strong Buy
  • OSK Buy
  • Analyst Count
  • MDGL 10
  • OSK 12
  • Target Price
  • MDGL $474.67
  • OSK $138.08
  • AVG Volume (30 Days)
  • MDGL 341.0K
  • OSK 570.8K
  • Earning Date
  • MDGL 10-30-2025
  • OSK 10-29-2025
  • Dividend Yield
  • MDGL N/A
  • OSK 1.50%
  • EPS Growth
  • MDGL N/A
  • OSK N/A
  • EPS
  • MDGL N/A
  • OSK 9.96
  • Revenue
  • MDGL $515,547,000.00
  • OSK $10,384,400,000.00
  • Revenue This Year
  • MDGL $394.12
  • OSK N/A
  • Revenue Next Year
  • MDGL $57.74
  • OSK $5.26
  • P/E Ratio
  • MDGL N/A
  • OSK $13.69
  • Revenue Growth
  • MDGL 3421.98
  • OSK 0.16
  • 52 Week Low
  • MDGL $200.63
  • OSK $76.82
  • 52 Week High
  • MDGL $457.16
  • OSK $144.30
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 62.88
  • OSK 49.11
  • Support Level
  • MDGL $415.53
  • OSK $133.06
  • Resistance Level
  • MDGL $440.90
  • OSK $137.64
  • Average True Range (ATR)
  • MDGL 14.27
  • OSK 3.04
  • MACD
  • MDGL -4.71
  • OSK -0.92
  • Stochastic Oscillator
  • MDGL 60.58
  • OSK 33.80

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About OSK Oshkosh Corporation (Holding Company)Common Stock

Oshkosh Corp is the top producer of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, where it is typically the market share leader in North America, or, in the case of JLG aerial work platforms. The company had manufactured joint light tactical vehicles for the U.S. Department of Defense. The company reports in three segments: Access, Vocational and Defense. It derives maximum revenue from Access Segment.

Share on Social Networks: